Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double curettage and cautery plus imiquimod for facial nodular basal cell carcinoma
2007-001961-14Phase 4Terminated
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Jun 2007
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imiquimod in basal cell carcinoma (BCC), sponsored by NHS Greater Glasgow and Clyde. Started Jun 2007; status: terminated.
02
Drugs
imiquimod
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on 2007-001961-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001961-14.